🇮🇳

Index Intelligence

· daily

BSE Auto Sector Regulatory Filings — October 22, 2026

The BSE AUTO stream for 22 October 2026 is dominated by Balkrishna Industries (BKT), which generated four of the nine filings: a Pirelli framework, offtake and service agreement (up to 800,000 Pirelli-branded premium car tyres by 2030 via an off-take first phase, with a 50:50 JV second phase conditional and restricted from competing JVs), a short-notice Business Update call, the audio recording intimation for that call, and a board-outcome press release. Material economic detail is largely absent: no consideration amounts, revenue, capex, or period-over-period financials are disclosed in any filing, so the enriched comparison, insider, capital-allocation and forward-guidance fields carry little quantitative content. The filings therefore cannot support period-over-period trend analysis; conclusions rest on qualitative terms. Samvardhana Motherson (SAMIL) announced a November 5, 2026 board meeting for Q2/H1 FY27 results plus a 17:00 IST earnings call the same day, while Hyundai Motor India schedules its Q2 FY2027 call for October 28 and Schaeffler India's Q3/9M call is October 29, with results on October 27. Ashok Leyland disclosed a senior HR executive's resignation effective October 21, with an open-ended willingness to remain until end-2026. Market implications centre on the BKT–Pirelli strategic pivot into premium car tyres, which is positive for capability build-out but carries a meaningful strategic-lock-in constraint, and on a dense near-term earnings calendar for auto and ancillary names.

9 medium 9 total filings
· daily

BSE FMCG Sector Regulatory Filings — October 22, 2026

Eight of the nine filings are Colgate-Palmolive (India) disclosures covering Q2 FY27 (quarter ended September 30, 2026), with the ninth being a Marico Limited climate press release that carries no financial content. Colgate posted net sales of Rs. 1,69,157 Lakh, up 12.2% YoY and 6.3% QoQ, and six-month sales up 12.1%, but reported net profit grew only about 4.3% YoY for the quarter and 5.6% for the half year, with profit excluding one-offs up about 5.5%. Profit before tax was essentially flat sequentially (Rs. 46,022 Lakh vs Rs. 46,219 Lakh in Q1) and rose only about 4.1% YoY, indicating that top-line momentum is not converting into bottom-line growth. The driver is cost inflation: advertising expense rose roughly 40% YoY to Rs. 31,482 Lakh (about 25% QoQ), and employee benefit costs rose about 15% YoY. The company also declared a Rs. 24 per share First Interim Dividend (Rs. 653 Crore aggregate; record date November 2, 2026; payment November 19, 2026) and announced a leadership change in Marketing, with Gunjit Jain resigning effective November 30 and Akash Parekh succeeding him December 1, alongside a postal ballot seeking approval of Manish Anandani as MD & CEO. Sentiment across the Colgate filings is uniformly mixed, and the materiality of the set is driven by the same underlying results rather than by independent events. Marico's filing is positive but immaterial to near-term earnings.

5 high priority 4 medium 9 total filings
· daily

BSE Pharma Sector Regulatory Filings — October 22, 2026

This BSE Pharma stream covers five filings dated 2026-10-22, all administrative in nature: no financial results, period-over-period figures, insider transactions, capital allocation actions, M&A terms, or forward guidance are disclosed in any of them. Mankind Pharma accounts for three filings (an earnings call time change from 6:00 P.M. to 5:00 P.M. IST on October 26, 2026, a repeat of that notice, and an in-person Mumbai analyst meet on October 27 that includes leadership of Armed Cell Therapeutics). Divi's Laboratories and IPCA Laboratories filed board-meeting and trading-window notices ahead of their Q2/H1 FY27 results on November 7 and November 5, 2026 respectively. The enriched-data fields requested (YoY/QoQ comparisons, guidance, insider activity) are therefore empty for this batch, so no quantitative cross-company comparison is possible. The actionable takeaway is calendar-driven: the results season for these names opens within two weeks, trading windows are closed for insiders across Divi's and IPCA, and the Mankind call and meet are the near-term information events.

5 medium 5 total filings
· daily

BSE Realty Real Estate Sector Regulatory Filings — October 22, 2026

Two filings fall in the S&P BSE REALTY stream for 22 October 2026: DLF Limited's Q2 FY27 earnings-call disclosures and Aditya Birla Real Estate's postal ballot for an ESOP scheme. DLF reported new sales bookings of approximately INR 3,800 crore, collections of INR 2,780 crore, operating cash flow of about INR 1,858 crore and a net cash position near INR 15,100 crore after a roughly INR 1,980 crore dividend payout. Headline profitability was flattered by a one-time INR 738 crore fair-valuation gain, with consolidated revenue of INR 2,298 crore, EBITDA of INR 1,060 crore and net profit above INR 1,300 crore. Management flagged a soft pre-sales quarter, a possible Q3 construction-outflow blip from labour migration and GRAP curbs, and a revenue inflection only in FY27-28 under completed-contract accounting, so near-term reported revenue quality should be read with caution. The ABREL filing is governance-oriented, with no financial period data, and proposes equity-based incentives capped at about 0.74% of paid-up capital, with e-voting closing 23 November 2026. Overall the stream shows a cash-rich developer with strong balance-sheet optics but lumpy, accounting-driven earnings, and a governance item with limited near-term market impact.

2 medium 2 total filings
· daily

BSE IT Technology Sector Regulatory Filings — October 22, 2026

Across the 13 filings for the India BSE IT stream (all dated 2026-10-22), the dominant story is Cyient Limited, which accounts for nine of the thirteen items and presents a mixed picture: Q2 FY27 consolidated revenue of ₹22,350 Mn rose 25.5% YoY, driven largely by the Kinetic Technologies and TAO Digital Solutions acquisitions, yet consolidated net profit fell 4.8% YoY to ₹1,214 Mn and standalone PAT dropped 28.3% YoY to ₹1,028 Mn. Organic growth in Cyient DET was far more modest (2.1% QoQ, 9.3% YoY) than reported growth (8.1% QoQ, 15.7% YoY), and the Semiconductors segment remains loss-making with its EBIT loss widening to ₹300 Mn from ₹235 Mn. Consolidated borrowings rose to ₹22,506 Mn and goodwill to ₹42,411 Mn, which raises the stakes on acquisition integration. LTIMindtree showed similar tension, with USD revenue up 5.1% YoY in constant currency and EBIT margin improving 10 bps QoQ to 15.6%, but PAT margin falling to 11.7% from 12.7% and operating cash flow conversion dropping to 39% of PAT. Tech Mahindra's postal ballot for a 1:1 bonus issue and authorised capital increase is the most structurally notable corporate action, while Mphasis's SBTi-validated net-zero targets are a sustainability rather than financial development. Overall, the sector shows growth reliant on M&A and currency rather than organic momentum, with management commentary pointing to supply constraints and uneven vertical demand.

3 high priority 10 medium 13 total filings
· daily

BSE Sensex 30 Stocks Regulatory Filings — October 22, 2026

Six filings were received for the BSE SENSEX 30 stream dated 2026-10-22, but the enriched data is thin: none of the filings contains period-over-period financial figures, insider transaction counts, guidance numbers, or capital allocation amounts beyond share counts and bonus ratios. The dominant theme is corporate-action and calendar activity rather than fundamental deterioration or improvement. Tech Mahindra's postal ballot for a 1:1 bonus issue and authorised capital increase is the most material development (materiality 6/10), with e-voting running 23 Oct to 21 Nov 2026 and a record date still to be set by the Board. InterGlobe Aviation (IndiGo) has scheduled its Q2 FY2027 results and earnings call for 29 Oct 2026, with a trading-window reopening 48 hours after declaration, which is the most time-sensitive catalyst in the set. NTPC's LIC disclosure cannot be interpreted because the summary omits share count, percentage, and direction, and its sector tag is inconsistent with the business. Axis Bank's ESOP allotment and Adani Ports' Omani subsidiary incorporation are routine and carry negligible market impact. Overall, the set supports a watchful, event-driven stance rather than a directional call.

6 medium 6 total filings
· daily

BSE Bankex Banking Sector Regulatory Filings — October 21, 2026

Four filings were published for the S&P BSE BANKEX stream on 21 October 2026, covering IDFC First Bank, State Bank of India, HDFC Bank and Bank of Baroda. The filings are predominantly governance and procedural in nature: an ESOP grant at IDFC First Bank, a Special Resolution postal ballot at HDFC Bank, and a Q2 FY2026-27 results board meeting notice at Bank of Baroda. The only filing with substantive risk content is State Bank of India's data-loss disclosure, where approximately 375,000 records surfaced on the dark web and 3,897 customer PII records were identified; the Bank states there is no material impact on operations or financials. No period-over-period financial metrics, insider transactions, or quantified guidance were disclosed in these filings, so quantitative trend analysis is limited for this cycle. The near-term catalysts are the Bank of Baroda Q2 results on 30 October 2026 and the trading-window reopening for Bank of Baroda on 2 November 2026. Overall the cycle is neutral, with cybersecurity and disclosure follow-through at SBI the principal item to monitor.

4 medium 4 total filings
· daily

BSE Metal Sector Regulatory Filings — October 21, 2026

Two filings from the S&P BSE METAL constituent universe were reviewed for 21 October 2026: APL Apollo Tubes Limited and Steel Authority of India Limited (SAIL). Both are procedural governance or event-scheduling disclosures rather than financial results releases, and neither contains period-over-period figures, guidance, insider transactions, capital allocation actions, or financial ratios, so the enriched quantitative fields are empty for this stream. Both sentiment readings are neutral with materiality scored 3/10. The most actionable information is the timetable: APL Apollo's Q2 and H1FY27 results call on 26 October 2026 at 5:00 PM IST, and SAIL's board meeting in October 2026 to approve its Q2 and H1FY27 results, with its trading window closed until 48 hours after the announcement. Portfolio-level signal for the metals sector is therefore limited to the near-term earnings cycle, and no directional conclusion on growth or margins can be drawn from these filings alone.

2 medium 2 total filings
· daily

BSE Auto Sector Regulatory Filings — October 21, 2026

Four BSE AUTO constituent filings were published on 21 October 2026, but none of them carries the enriched financial data the brief anticipates: there are no period-over-period revenue, margin, or earnings figures, no insider transactions, no capital allocation changes, and no guidance. The filings are procedural: an ESG score assignment for Tata Motors (score 71, 'Leader' category), an investor call intimation for TVS Motor, a board-meeting and trading-window notice for Hyundai Motor India, and an earnings-call schedule notice for Maruti Suzuki. The substantive takeaway is a dense calendar cluster: Maruti's call on 27 October, Hyundai's board meeting on 28 October, and TVS's investor call on 28 October all fall within the same week, meaning Q2 FY27 results and commentary from three of the four names will arrive almost together. Trading windows for Hyundai insiders have already been closed since 1 October, a standard pre-results restriction rather than a signal. Because the filings contain no figures, no quantitative peer comparison is possible, and any investment view should wait for the results themselves. Materiality across the set is low (2-3/10).

4 medium 4 total filings
· daily

BSE FMCG Sector Regulatory Filings — October 21, 2026

This stream covers two filings from S&P BSE FMCG constituents, both of which are administrative or governance intimations rather than financial disclosures. Hindustan Unilever has scheduled its earnings call and analyst presentation for 28 October 2026 covering the quarter and half year ended 30 September 2026, but the filing carries no financial figures, so no period-over-period trends can be drawn from it. Nestle India disclosed a senior management reshuffle effective 1 January 2027 that moves its Nutrition and Dairy and Chocolates and Confectionery leadership, signalling an internal re-organisation rather than a change in financial outlook. The enriched data available for these two filings contains no period comparisons, insider trading, capital allocation, transaction, or quantitative guidance fields, so portfolio-level growth or margin analysis is not possible from this batch. The main market implication is the near-term catalyst of HUL's results call on 28 October, which will be the first substantive data point for the sector in this window. Investors should treat both items as low-materiality and monitor for the results release rather than act on these filings alone.

2 medium 2 total filings
· daily

BSE Pharma Sector Regulatory Filings — October 21, 2026

Three filings from the S&P BSE Pharma constituent set are in scope for 2026-10-21: two Zydus Lifesciences market notices (a Zylidac Bio CDMO partnership with Prolific Machines and a USFDA final approval for a transdermal estradiol/levonorgestrel ANDA) and one Dr. Reddy's Laboratories notice on CDSCO approval of toripalimab (Zytorvi) for first-line esophageal squamous cell carcinoma. All three are positive in sentiment, but materiality is modest (3-5/10), and none of the filings disclose financial figures, period-over-period comparisons, insider transactions, capital allocation actions, or forward guidance, so the enriched fields for quantitative trend analysis are largely empty. The most commercially relevant item is the Zydus USFDA approval, which carries roughly USD 45.7 mn of annual US sales (IQVIA MAT Aug-2026) and a 180-day Competitive Generic Therapy exclusivity window contingent on first commercial marketing. Zydus's ANDA approval count reached 458 against 516 filed as of 30 September 2026, implying an approval rate of about 89% of filings. The Dr. Reddy's approval extends Zytorvi's Indian footprint into a second indication, supported by Phase 3 JUPITER-06 data showing a 42% reduction in progression/death risk and median overall survival of 17.7 versus 12.9 months. Collectively the flow points to steady pipeline execution rather than a step change, with the Zydus CDMO move the only one with a longer-dated platform implication.

3 medium 3 total filings
· daily

BSE Realty Real Estate Sector Regulatory Filings — October 21, 2026

This digest covers a single filing from Aditya Birla Real Estate Limited, an S&P BSE REALTY constituent, and it is a scheduling notice rather than a results disclosure. The company will hold its earnings conference call for Q2/H1 FY2026-27 on Monday, 26 October 2026 at 5:00 PM IST, moderated by Ambit Capital's Karan Khanna. The filing contains no financial figures, so no period-over-period revenue, margin, or ratio trends can be drawn from it, and no insider, capital allocation, or transaction data was disclosed. Sentiment is neutral with materiality rated 3/10. The actionable takeaway is the upcoming call as the first real source of Q2/H1 numbers, which investors should treat as the key event to monitor.

1 medium 1 total filings
· daily

BSE IT Technology Sector Regulatory Filings — October 21, 2026

The 'India BSE IT' stream for 2026-10-21 is dominated by a single corporate event: Persistent Systems' Qualified Institutional Placement of up to USD 450 million (about INR 42,646 million), with a floor price first disclosed at INR 5,550 and then clarified to INR 5,761.00 per share, plus a CRISIL 'AA+; Rating Watch with Developing Implications' rating on proposed NCDs. The filings contain no period-over-period operating data, margin trends, insider activity, or forward-looking guidance, so the enriched fields available for this batch are largely empty, and conclusions about growth or margin trajectories cannot be drawn from them. The remaining in-scope items are operational and event-driven: KPIT's post-earnings call on October 28, 2026 (Q2 FY2027 results due the same day), and LTM and HCLTech product or AI-offering launches that are positive in tone but unquantified. The inconsistency between the two Persistent floor-price figures (INR 5,550 versus INR 5,761.00) is the single most important item to verify against the exchange letters before acting. All seven filings are in scope; none are excluded.

2 high priority 5 medium 7 total filings
· daily

BSE Sensex 30 Stocks Regulatory Filings — October 21, 2026

Across the 14 filings for the BSE SENSEX 30 stream dated 21 October 2026, the dominant story is Eternal Limited, which accounts for five of the 14 filings and carries the most material information: Q2 FY27 headline growth was strong (consolidated revenue from operations of INR 24,138 crore, up roughly 78% YoY; Adjusted Revenue up 76% YoY; Adjusted EBITDA of INR 666 crore, up 197% YoY), but like-for-like growth was a lower 58%, consolidated total comprehensive income swung to a loss of INR (311) crore on fair-value losses, Food delivery EBITDA margin slipped to 5.5% of NOV, and Going Out remained loss-making. Financial-sector and conglomerate balance sheets show increasing leverage: Reliance's ICRA rating affirmation came with debt rising to Rs. 3,98,000 crore and interest coverage moderating to 5.7x from 6.6x, while Bajaj Finance raised Rs. 2,120 crore via zero-coupon secured NCDs. Defence and infrastructure remain order-driven, with Bharat Electronics adding Rs. 1,011 crore of orders since 13 October and L&T winning two large public-sector building contracts whose values were undisclosed. Governance and cyber risk surfaced at State Bank of India, where a data-loss incident involved 3,897 customer PII records, though management says there is no material impact. Most other filings are procedural (earnings call intimations, postal ballots, monitoring reports), so the actionable signal set is concentrated in Eternal, Reliance, SBI, BEL and L&T.

4 high priority 10 medium 14 total filings
· daily

BSE Bankex Banking Sector Regulatory Filings — October 20, 2026

Both in-scope filings concern Yes Bank Limited, a BSE BANKEX constituent, so this session offers a single-company read rather than a cross-sector comparison. The primary development is a Moody's affirmation of the Ba1 deposit and issuer ratings and ba2 BCA with a Stable outlook, which is offset by an expected pro-forma CET1 decline from 13.7% to 11.4% following the Supreme Court's October 15, 2026 ruling reinstating AT1 securities. Tier 1 is unchanged, and the reinstatement brings a one-time negative hit to profitability. Moody's has set a downgrade trigger at TCE/RWA below 11% absent a credible capital-raising plan, which makes the 11.4% pro-forma level only about 40 bps above that threshold. Qualitative credit concerns include rapid SME and retail growth via third-party sourcing, weaker funding than large Indian peers, and provisioning costs expected to normalise from cyclical lows as legacy recoveries fade. A second filing corrected cover-page wording in the October 17, 2026 board outcome, changing the auditors' conclusion on Q2 FY27 and H1 results from a 'modified opinion' to a 'qualified conclusion' in the Limited Review Report; the correction is clerical in scope but touches audit-opinion language, which investors will scrutinise. The enriched dataset provided no period-over-period figures, insider transactions, dividend or buyback data, or forward guidance, so quantitative trend and insider analysis is not possible for this session.

1 high priority 1 medium 2 total filings
· daily

BSE Metal Sector Regulatory Filings — October 20, 2026

This quiet session covered a single filing from Vedanta Limited, disclosed under Regulation 30(9), concerning its subsidiary Hindustan Zinc Limited's approved unaudited results for Q2 and H1 FY27 (quarter and half year ended September 30, 2026). Year-over-year, consolidated revenue from operations rose to Rs. 15,093 Crore from Rs. 8,549 Crore (roughly +77%), and Q2 net profit more than doubled to Rs. 5,412 Crore from Rs. 2,649 Crore, reflecting strong operating leverage in the metals and mining business. Sequentially, however, momentum softened: revenue grew only about 9.8% from Rs. 13,747 Crore in Q1, and net profit eased roughly 1% from Rs. 5,469 Crore, while other comprehensive income swung negative at Rs. (32) Crore. The statutory auditor issued an unmodified limited review opinion, but unaudited subsidiary figures were not reviewed by the principal auditor, a reliance point investors should note. Overall the sentiment is mixed: the annual comparison is very strong, while the sequential deceleration signals that the earnings upcycle may be plateauing. Given the single-filing nature of the session, no cross-company sector pattern can be drawn, and the read-through rests on Vedanta's own trajectory.

1 medium 1 total filings
· daily

BSE Auto Sector Regulatory Filings — October 20, 2026

This BSE AUTO stream covers only two filings dated October 20, 2026, and both are sparse on the enriched fields the brief expects. Schaeffler India (BSE AUTO constituent) disclosed the custodial arrest of its CEO & Managing Director under the Bharatiya Nyaya Sanhita, 2023, linked to a June 9, 2026 CO2 discharge accident at its Talegaon factory that killed two service-provider workers; the company says senior management continues normal operations. TVS Motor's filing is a credit-rating update in which CARE reaffirmed its debentures and bank facilities at CARE AAA/Stable and enlarged several facility limits, with no downgrades. No period-over-period comparisons, forward guidance, insider transactions, capital allocation actions, or valuation data were supplied for either company, so portfolio-level trend analysis cannot be drawn from this batch. The dominant market implication is governance and operational-safety risk at Schaeffler India, partly offset by TVS Motor's stable credit profile. Investors should treat this as a thin dataset and seek the full filings before acting.

1 high priority 1 medium 2 total filings
· daily

BSE Pharma Sector Regulatory Filings — October 20, 2026

Two filings were published in the BSE Pharma stream for 2026-10-20, both from constituent companies (Lupin Limited and Sun Pharmaceutical Industries). The enriched period-over-period, insider, capital allocation and financial ratio fields were not populated for either filing, so no quantitative YoY/QoQ trends, insider transactions, guidance changes or margin data can be drawn from this batch. The substantive developments are a routine employee stock option grant at Lupin (neutral, low materiality, 2/10) and a positive clinical-regulatory update for Sun Pharma's UNLOXCYT (cosibelimab) being elevated to an NCCN Category 2A recommendation for locally advanced cutaneous squamous cell carcinoma (3/10). Market implications are limited: the Lupin grant is a standard compensation action with dilution impact at a nominal exercise price, while the Sun Pharma update strengthens the oncology franchise's guideline positioning in a niche indication. No cross-company sector pattern can be established from two filings, and the batch is best treated as low-signal.

2 medium 2 total filings
· daily

BSE Sensex 30 Stocks Regulatory Filings — October 20, 2026

This digest covers four filings dated 20 October 2026 for the BSE SENSEX 30 stream. Only the Titan Company Limited filing is an in-scope SENSEX constituent with a clear board-calendar signal, while the NTPC and Sun Pharmaceutical filings are in-scope constituents with material but non-financial disclosures. The enriched period-over-period, insider, capital allocation and financial ratio fields are absent from the supplied summaries, so no quantitative YoY/QoQ trends can be verified from these four filings and the analysis relies on qualitative disclosure content. The most actionable item is the Titan board meeting on 5 November 2026 that will publish Q2 FY27 results, with the trading window closed until 48 hours after. NTPC's denial of a misreported buyback and the Sun Pharma regulatory milestone (NCCN Category 2A for UNLOXCYT in laCSCC) are the other material developments. UltraTech's routine ESOP grant is a low-materiality governance item with no financial impact.

1 high priority 3 medium 4 total filings
· daily

BSE Bankex Banking Sector Regulatory Filings — October 19, 2026

The BSE BANKEX stream for 19 October 2026 is dominated by Union Bank of India's Q2 FY27 results cycle, which generated a cluster of filings (governance, investor presentation, market update, and market notice) that together paint a strong headline profit story with mixed underlying quality. Standalone net profit rose about 30% YoY to ₹5,537 Cr and H1 PAT grew roughly 30% to ₹10,870 Cr, while gross NPA fell to 2.42% from 3.29% and CRAR stood at 17.94%. Beneath the headline, growth quality is uneven: global advances grew 18.53% YoY against deposit growth of only 6.87%, pushing the CD ratio to 88.13% from 79.67%, domestic CASA slipped 17 bps QoQ to 34.93%, and cost-to-income worsened 144 bps QoQ with operating expenses up 7.4% QoQ. Provisions fell sharply YoY (₹70,075 lakh vs ₹1,39,673 lakh) but rose sequentially, and the bank has been building contingency buffers, so the sustainability of the provisioning tailwind is an open question. Private peers Kotak Mahindra Bank and YES Bank have announced or hosted earnings calls for Q2/H1 FY27 but their filings carry no financial figures, so the stream currently offers no comparative performance read on them. The Federal Bank cluster (exchange clarification query, a rumour-verification response denying undisclosed acquisition talks) is the main event-risk item, with the MD/CEO reportedly saying the bank is open to deals but not in active talks. Overall the sector read is constructive on earnings and asset quality, with funding cost and liability franchise trends warranting monitoring.

4 high priority 6 medium 10 total filings